[Biomarkers for prognosis of response to anti-TNF therapy of rheumatoid arthritis: Where do we stand?]

Z Rheumatol. 2015 Nov;74(9):812-8. doi: 10.1007/s00393-014-1543-4.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antirheumatic Agents / administration & dosage
  • Arthritis, Rheumatoid / diagnosis
  • Arthritis, Rheumatoid / drug therapy
  • Biomarkers / metabolism
  • Cytokines / metabolism*
  • Genetic Markers / genetics*
  • Humans
  • Polymorphism, Genetic
  • Polymorphism, Single Nucleotide / genetics
  • Prognosis
  • Proteome / metabolism*
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Biomarkers
  • Cytokines
  • Genetic Markers
  • Proteome
  • Tumor Necrosis Factor-alpha